Free Trial

Hims & Hers Health (HIMS) Stock Price, News & Analysis

Hims & Hers Health logo
$56.37 -1.65 (-2.84%)
As of 12:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Hims & Hers Health Stock (NYSE:HIMS)

Key Stats

Today's Range
$55.60
$57.60
50-Day Range
$41.40
$64.47
52-Week Range
$13.47
$72.98
Volume
14.98 million shs
Average Volume
33.61 million shs
Market Capitalization
$12.62 billion
P/E Ratio
82.64
Dividend Yield
N/A
Price Target
$39.83
Consensus Rating
Reduce

Company Overview

Hims & Hers Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
51st Percentile Overall Score

HIMS MarketRank™: 

Hims & Hers Health scored higher than 51% of companies evaluated by MarketBeat, and ranked 513th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Hims & Hers Health has received a consensus rating of Reduce. The company's average rating score is 1.92, and is based on 2 buy ratings, 8 hold ratings, and 3 sell ratings.

  • Amount of Analyst Coverage

    Hims & Hers Health has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Hims & Hers Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Hims & Hers Health are expected to grow by 79.31% in the coming year, from $0.29 to $0.52 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Hims & Hers Health is 82.10, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.71.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Hims & Hers Health is 82.10, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.00.

  • Price to Earnings Growth Ratio

    Hims & Hers Health has a PEG Ratio of 1.84. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Hims & Hers Health has a P/B Ratio of 26.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Hims & Hers Health's valuation and earnings.
  • Percentage of Shares Shorted

    35.39% of the float of Hims & Hers Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Hims & Hers Health has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Hims & Hers Health has recently increased by 10.80%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Hims & Hers Health does not currently pay a dividend.

  • Dividend Growth

    Hims & Hers Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    35.39% of the float of Hims & Hers Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Hims & Hers Health has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Hims & Hers Health has recently increased by 10.80%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Hims & Hers Health has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 74 news articles for Hims & Hers Health this week, compared to 29 articles on an average week.
  • Search Interest

    165 people have searched for HIMS on MarketBeat in the last 30 days. This is an increase of 18% compared to the previous 30 days.
  • MarketBeat Follows

    62 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is an increase of 72% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Hims & Hers Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $41,519,462.00 in company stock.

  • Percentage Held by Insiders

    13.71% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    63.52% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Hims & Hers Health's insider trading history.
Receive HIMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter.

HIMS Stock News Headlines

Why Elon put $51 million into this
A single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re quietly shipping 30 tons per year from a facility outside San Antonio.
hims and hers stock dip - This image is an original composition by MarketBeat using licensed and editorial elements. Not for redistribution or reuse.
Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback
Hims & Hers stock dipped after Novo Nordisk pulled back its partnership for a weight loss drug distribution, though that may not mean much.
Is Hims & Hers the Newest Meme Stock Darling?
Is Hims & Hers the Newest Meme Stock Darling?
See More Headlines

HIMS Stock Analysis - Frequently Asked Questions

Hims & Hers Health's stock was trading at $24.18 at the beginning of the year. Since then, HIMS stock has increased by 133.4% and is now trading at $56.4420.

Hims & Hers Health, Inc. (NYSE:HIMS) posted its quarterly earnings results on Monday, May, 5th. The company reported $0.20 earnings per share for the quarter, beating analysts' consensus estimates of $0.12 by $0.08. The company's revenue was up 110.7% on a year-over-year basis.
Read the conference call transcript
.

Hims & Hers Health's top institutional investors include Salem Investment Counselors Inc. (0.12%), QRG Capital Management Inc. (0.08%), Fiduciary Alliance LLC (0.05%) and Abacus FCF Advisors LLC (0.02%). Insiders that own company stock include Melissa Baird, David B Wells, Alex Bard, Michael Chi, Patrick Harrison Carroll, Soleil Boughton, Christopher D Payne, Andrew Dudum, Oluyemi Okupe, Christiane Pendarvis, Anja Manuel, Irene Becklund, Irene Becklund and Lynne Chou O'keefe.
View institutional ownership trends
.

Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hims & Hers Health investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
5/05/2025
Today
7/24/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Healthcare
Current Symbol
NYSE:HIMS
CIK
1773751
Fax
N/A
Employees
1,637
Year Founded
N/A

Price Target and Rating

High Price Target
$68.00
Low Price Target
$26.00
Potential Upside/Downside
-31.3%
Consensus Rating
Reduce
Rating Score (0-4)
1.92
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.69
Trailing P/E Ratio
84.06
Forward P/E Ratio
200.00
P/E Growth
1.84
Net Income
$126.04 million
Net Margins
9.24%
Pretax Margin
6.71%
Return on Equity
22.75%
Return on Assets
15.51%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.59
Quick Ratio
1.32

Sales & Book Value

Annual Sales
$1.48 billion
Price / Sales
8.79
Cash Flow
$0.41 per share
Price / Cash Flow
142.01
Book Value
$2.16 per share
Price / Book
26.85

Miscellaneous

Outstanding Shares
223,830,000
Free Float
193,145,000
Market Cap
$12.98 billion
Optionable
Optionable
Beta
2.02

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NYSE:HIMS) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners